PULMONARY SURFACTANT IS ESSENTIAL for normal lung function (34) . By reducing surface tension at the air-liquid interface of the lung, surfactant optimizes pulmonary compliance, thus reducing the work of breathing and providing a larger surface area for gas exchange. Proper surfactant function is highly dependent on its composition, consisting of phospholipids (PL) (80 -85%), surfactant-associated proteins SP-A, SP-B, SP-C, and SP-D (5-10%), cholesterol (5-10%), and other neutral lipids (1-2%) (11) . Altered surfactant composition, such as that observed in patients with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), may represent a significant contributing factor to lung dysfunction associated with these disorders (14, 35) .
Mechanical ventilation (MV) is an essential supportive therapy in all patients with ALI/ARDS to maintain adequate gas exchange (1) . Unfortunately, MV can also contribute to the progression of lung injury (9, 25) . Two aspects of MV shown to contribute to this progression are the overdistension and repetitive collapse of alveoli (9, 26) . The mechanisms by which these aspects contribute to lung injury can be studied in normal animals by using a high-tidal volume (Vt) and no positive end-expiratory pressure (PEEP). The resulting damage to the lung is termed ventilator-induced lung injury (VILI). Alterations to surfactant represent one of the main mechanisms by which overdistension and collapse induce damage during the progression of VILI (2, 23, 36, 37, 38) . Changes to the surfactant system such as decreased levels of surfactant proteins, altered lipid composition, and the association of serum proteins leaked in from the capillaries are all believed to contribute to the dysfunction of surfactant, and, consequently, decreased lung function (23, 39) .
The most extensively studied mechanism of surfactant dysfunction is serum protein inhibition (6, 17, 32) . Despite the strong evidence supporting this role of serum protein inhibition, a recent study by our lab demonstrated that alterations to surfactant composition itself also contributed to the impairment of biophysical function in VILI (23) . Quantification of several surfactant components revealed a significant increase in the level of cholesterol in surfactant from animals with VILI. This observation, and the recent studies demonstrating that the addition of supraphysiological levels of cholesterol to exogenous surfactant preparations inhibit surfactant function in vitro (12, 13, 18, 20) , led to our hypothesis that cholesterol significantly contributes to surfactant dysfunction in VILI.
To address this hypothesis, surfactant was isolated from adult rats that had VILI induced by high-tidal volume ventilation and from control ventilated animals. The biophysical properties of the isolated surfactants were analyzed on the captive bubble surfactometer (CBS) with and without the removal of cholesterol using methyl-␤-cyclodextrin (M␤CD).
MATERIALS AND METHODS
Animal experimentation. A total of 30 male Sprague-Dawley rats (Charles River, St. Constant, PQ, Canada), weighing 350 -430 g, were included in this study. All procedures were approved by the animal use subcommittee at the University of Western Ontario, under the guidelines of the Canadian Council of Animal Care.
Animal surgery and ventilation were performed as previously reported (23) . Briefly, the mass of the rat was recorded, the animals were anesthetized, and both jugular veins and the right carotid artery were exposed and cannulated to deliver anesthetic/analgesic (0.5-2.0 mg ⅐ 100 g Ϫ1 ⅐ h Ϫ1 propofol), a neuromuscular inhibitor (0.2 ml ⅐ h 2.2 mg Ϫ1 ⅐ ml Ϫ1 pancuronium bromide), and fluid (0.5 ml ⅐ 100 g Ϫ1 ⅐ h
Ϫ1
sterile NaCl and 100 IU heparin/l). The carotid line was used to monitor blood pressure and heart rate and to obtain arterial blood samples for blood gas measurements (model ABL 500; Radiometer, Copenhagen, Denmark). Subsequently, the trachea was exposed, and a 14-gauge endotracheal tube was inserted and secured using 2-0 surgical silk. The animal was immediately connected to a volumecycled rodent ventilator (Harvard Instruments, St. Laurent, PQ, Canada) using a low Vt ventilation strategy (Vt of 8 ml/kg), a PEEP of 5 cmH 2O, a rate of 56 -58 breaths/min (bpm), and a fraction of inspired oxygen (FI O 2 ) of 1.0. Animals meeting inclusion criteria for the study had an arterial partial pressure of oxygen to fraction of inspired oxygen ratio (Pa O 2 /FIO 2 ) of Ͼ400 mmHg, an arterial partial pressure of carbon dioxide (Pa CO 2 ) between 35 and 45 mmHg, and a peak inspiratory pressure (PIP) of Ͻ15 cmH 2O. These criteria resulted in the exclusion of four animals from the study. Animals meeting inclusion criteria were randomized to receive 2 h of either a low Vt ventilation strategy as described above, or a high Vt ventilation strategy (Vt ϭ 30 ml/kg), with a PEEP ϭ 0 cmH 2O, a respiratory rate ϭ 15-17 bpm, and an FI O 2 ϭ 1.0 (23) . A second ventilator that was calibrated to deliver a Vt of 30 ml/kg was used for animals randomized to the high Vt strategy. After meeting inclusion criteria, all animals were disconnected from the ventilator for 5 s and reconnected to the ventilator of the appropriate strategy. PIP was monitored throughout ventilation, and arterial blood gas measurements were taken at baseline and every 15 min thereafter.
Isolation of surfactant. Following 2 h of either low or high Vt ventilation, animals were killed with an overdose of pentobarbital sodium (0.2-0.6 ml at 65 mg/ml) administered intravenously to lower blood pressure and exsanguinated via transection of the descending aorta. A midline sternectomy was performed to expose and visualize the lungs followed by determination of the pressure-volume curve (23) . A whole lung lavage procedure was performed as previously described, and differential centrifugation was used to isolate the pellet containing the large aggregate (LA) subfraction of surfactant (21) . The LA pellet was resuspended in 2 ml of 0.15 M sterile saline and was extracted by the method of Bligh and Dyer (4) . The amount of phospholipids in the chloroform extract was quantified using a DuckChong phosphorus assay (10) . The remainder of the LA fraction for each animal was lipid extracted, dried under nitrogen (N2), and stored at Ϫ20°C for further analysis.
Assessment of surface tension. Before surface tension assessment, each LA surfactant sample was resuspended to a concentration of 27 mg/ml in buffer (140 mM NaCl, 10 mM HEPES, and 2.5 mM CaCl2, pH 6.9). The surface activity of the surfactants was assessed using a previously described, computer-controlled CBS (12, 31) . Briefly, the chamber of the CBS was filled with a buffer solution (140 mM NaCl, 10 mM HEPES, and 2.5 mM CaCl2, pH 6.9) containing 10% sucrose (by mass) to increase the buffer density above that of surfactant. A small bubble (0.035-0.045 ml) was introduced into the chamber and allowed to float up and rest against the concave agarose plug at the top of the chamber. Approximately 0.1-0.15 l of LA sample was deposited just below the air-liquid interface by a transparent capillary attached to a micromanipulator used for the precise approach of the capillary to the bubble (12) . The bubble was imaged using a video camera (Pulnix TM-7CN, S/N: 017505) and recorded for future analysis. Throughout the experiment, the chamber was kept at 37°C. Upon injection of surfactant, a 5-min adsorption period (initial adsorption) was allowed, during which time there was no manipulation of the bubble, and the change in the shape of the bubble was monitored. The chamber was then sealed and the bubble was rapidly expanded to a volume of 0.13 ml over a 1-s interval. Again, a 5-min period was allowed to monitor the change in bubble shape (rapid expansion). Following this 5-min period, a quasistatic cycle was performed by compressing and then expanding the bubble in a stepwise manner in increments of 20% of the total volume to set the minimum (0.0090 ml) and maximum bubble volume (0.13 ml) for subsequent assessment (12) . Dynamic cycling, in which the bubble volume was smoothly changed to the defined volumes for 20 cycles at a rate of 20 cycles/min, was then performed to determine the minimum achievable surface tension during compression (minimum surface tension, MST). The surface tensions of the bubbles were calculated based on the shape of the bubble at various stages throughout the CBS technique. Briefly, during initial adsorption and rapid expansion, images at precisely 0, 1, 5, 10, 30, and 300 s were analyzed for surface tension. During dynamic cycling, every fifth image was analyzed, and the lowest minimum surface tensions that were achieved for cycles 1, 2, 5, 10, and 20 were determined.
Evaluating the effect of cholesterol. Two separate protocols were utilized to remove cholesterol from the extracted LA samples by M␤CD (Sigma-Aldrich, cat. no. M7439-1G). In experiment 1, LA samples were injected into the chamber of the CBS, which contained either buffer alone, as described above, or a buffer containing 20 mM M␤CD to remove cholesterol from the injected sample (28, 31, 42) . Samples were then incubated within the bubble chamber for 1 h following the initial adsorption step as described above. Thus, this experiment tested four experimental conditions for the isolated LA: 1) LA from low Vt injected in a control buffer, 2) LA from low Vt injected in M␤CD-containing buffer, 3) LA from high Vt injected in a control buffer, and 4) LA from high Vt injected in M␤CD-containing buffer.
In experiment 2, cholesterol was removed from the extracted samples in a test tube before injection into the CBS. Based on preliminary experiments, aliquots of the extracted LA were resuspended in 2 ml of 5 mM M␤CD solution in saline, whereas another aliquot was resuspended in saline as a control. The samples were incubated overnight at 37°C. After incubation, the volumes were centrifuged at 40,000 g to remove the M␤CD and isolate the LA pellets, which were resuspended in a 2-ml aliquot of saline. The resuspended LA were then centrifuged again at 40,000 g, and the remaining LA pellet was resuspended in saline again, and an aliquot was taken to determine PL phosphorus content (10) . Of note, this technique for cholesterol removal was characterized using radioactive cholesterol and several different surfactant preparations varying in their cholesterol content. The results demonstrated the removal of 80 -85% of the cholesterol from all preparations. In addition, a separate experiment showed that M␤CD treatment of LA from either normal rats or rats exposed to either low Vt or high Vt ventilation did not result in changes in the molecular species of phosphatidylcholine and phosphatidylglycerol, as assessed by mass spectrometry analysis.
To validate that the potential differences in biophysical function in this experiment were specifically due to cholesterol removal, cholesterol was added back to values corresponding to those observed in either low Vt or high Vt samples. M␤CD-incubated samples obtained from animals that were ventilated using low Vt MV were supplemented back to a final concentration of 8% cholesterol, and the high Vt M␤CD group was supplemented to 13% cholesterol. Finally, extracted samples that were not incubated with M␤CD from the low Vt group were supplemented with an additional 5% cholesterol, to increase the final concentration of cholesterol to the 13% that was observed in the high Vt group (23) .
Thus, experiment 2 involved the surface tension assessments of seven different conditions: 1 and 2) saline incubated samples from both low Vt and high Vt groups, 3 and 4) M␤CD-incubated samples from both low Vt and high Vt groups, 5 and 6) cholesterol-supplemented, M␤CD-incubated samples from both low Vt and high Vt groups, and 7) cholesterol-supplemented sample from the low Vt group.
Statistical analysis. All values are reported as means Ϯ SE. Statistical analysis was performed using a two-way repeated measures ANOVA to investigate differences over time, with a Tukey post hoc test to investigate one-way interactions between groups. Surface tension assessments in experiment 1 were also analyzed using a three-way ANOVA followed by a two-way ANOVA to investigate any interactions of effects. Two-way repeated measures ANOVAs were performed using SigmaStat for Windows, version 3.0 (Systat Software, San Jose, CA). Three-way ANOVAs were performed using SPSS version 16.0 for Windows (SPSS, Chicago, IL). Values are considered significantly different at P Ͻ 0.05.
RESULTS
Animal experimentation. The mean mass of animals in this study was 391 Ϯ 3 g, with no significant differences between groups. Physiological parameters during the 2-h ventilation period for animals in both experiments are shown in Table 1 O) at every time point compared with the low Vt group. Analysis over time showed that within the high Vt group, measurements of PIP at 90, 105, and 120 min were significantly higher than the 0-min value within this group (results not shown). Measurements of the pressure-volume curves postventilation indicated that animals receiving high Vt MV had significantly lower compliance than low Vt animals, as indicated by a shift downward and to the right in the pressure-volume curve (results not shown). The maximum sustainable volume (Vmax) at 26 cmH 2 O pressure was significantly lower in animals from the high Vt group compared with animals receiving low Vt ventilation (29.8 Ϯ 1.5 ml/kg vs. 39.4 Ϯ 0.9 ml/kg). In general, these physiological parameters are consistent with VILI and with previous studies utilizing this specific experimental model (23, 40) . Isolated surfactant LA samples from the low Vt animals have 5-7% cholesterol, which is similar to that found in normal, nonventilated rats. Isolated surfactant LA samples from the high Vt animals had 12-14% cholesterol.
Surface activity measurements: experiment 1. Following collection of the surfactant LA fraction from the two ventilation groups, experiment 1 evaluated the effect of cholesterol on the surface activity via the inclusion of M␤CD within the buffer of bubble chamber. Surface tension measurements during the initial adsorption of surfactant to the air-liquid interface for the four experimental groups are shown in Fig. 1 . In the presence of the control buffer, low Vt samples reached equilibrium surface tension (20 -23 mN/m) within 10 s and maintained that value over the entire 5-min period. There was no significant difference at 0 s between high Vt and low Vt samples; however, at every time point thereafter, high Vt samples exhibited significantly higher surface tension values compared with the low Vt samples (Fig. 1A) . Similar results were obtained in the presence of M␤CD in the chamber of the CBS (Fig. 1B) with high Vt samples exhibiting significantly higher surface tension values compared with low Vt samples. Surface tension of M␤CD-containing buffer at 0 s, before surfactant injection, was significantly lower compared with control buffer since M␤CD possesses slight surface active properties (Fig. 1, B vs. A) . At every time point analyzed thereafter, M␤CD exhibited no effect on surface tension reduction within each ventilation strategy, as low Vt with the M␤CD buffer was not different from low Vt with control buffer, and high Vt with M␤CD buffer was not different from high Vt with control buffer (Fig. 1, B vs. A) .
Following adsorption measurements and the subsequent incubation with either control or M␤CD buffer, the bubble inside the CBS chamber was rapidly expanded with a further measurement of surface tensions over a 5-min period. No significant differences between low Vt and high Vt samples were observed when analyzed in the control buffer. In addition, there were no significant differences between low Vt in M␤CD buffer and in control buffer or between high Vt in M␤CD buffer and in control buffer. High Vt in M␤CD buffer was also Subsequent to the rapid expansion measurements, samples underwent dynamic compression-expansion cycles of the bubble. Representative isotherms of a sample from each of the individual groups are shown in Fig. 2 . For each of the samples, the area compression was ϳ80%, which was similar among all groups and was maintained over consecutive cycles. In addition, all samples showed hysteresis, which was reduced over consecutive cycles. For statistical comparisons among groups, the MST values were recorded and are shown in Fig. 3 . Comparison of the low Vt group to the high Vt group analyzed in the control buffer revealed significantly higher MST values for cycles 1, 2, and 5 in the high Vt group (Fig. 3A) . In contrast, samples evaluated in M␤CD-containing buffer demonstrated no differences between high Vt and low Vt samples for any of the cycles analyzed (Fig. 3B) . Statistical comparison of the two low Vt groups revealed no significant differences between any of the cycles except for cycle 20 in which the MST value in the low Vt M␤CD buffer group was significantly lower than the low Vt control buffer group. Comparison of high Vt in control buffer compared with high Vt sample in M␤CD buffer revealed significantly lower MST values for all cycles analyzed in the latter group.
In addition to comparisons between the MST of samples from the different experimental groups, samples were also analyzed for changes in MST over the different dynamic cycles. Low Vt samples in control buffer achieved the lowest MST in the first cycle, which increased significantly over subsequent cycles (Fig. 3A) . Surfactant samples in the other three conditions maintained their respective MST values over all cycles analyzed.
Surface activity measurements: experiment 2. To further elucidate the role of cholesterol in surface tension impairment due to high Vt ventilation, samples were incubated with M␤CD before analysis. Surface tension during the initial adsorption of LA to the air-liquid interface is shown in Fig. 4 for the untreated samples, the M␤CD-treated samples, and for the three samples in which cholesterol was added. As shown in Fig. 4A , comparison of the two untreated groups revealed that high Vt exhibited a significantly higher surface tension over all time points than the low Vt group. After M␤CD treatment (Fig.  4B) , the adsorption characteristics of samples obtained from the low Vt and high Vt groups were similar. Comparison of the untreated low Vt with the M␤CD-treated low Vt group (Fig. 4 , A vs. B) revealed that the M␤CD group had significantly higher surface tension values at 1, 5, and 10 s; however, no differences existed at 30, 60, or 300 s. Statistical comparison of the two groups of samples from animals receiving high Vt MV revealed no significant differences at time points up to 60 s; however, at 300 s, surface tension values for the M␤CD-treated high Vt group were significantly lower compared with the untreated high Vt samples.
As shown in Fig. 4C , samples from the M␤CD-treated low Vt and high Vt groups in which cholesterol was added back to its original values revealed rapid adsorption for the low Vt group and slower adsorption for the high Vt group. These values were similar to those observed in the untreated samples at all time points analyzed (Fig. 4, A vs. C) . Finally, untreated samples from the low Vt group, to which cholesterol was supplemented to levels similar as those observed in the high Vt group, had adsorption values that were similar to the untreated high Vt group (Fig. 4, A and C) .
Surface tension during rapid expansion of the samples shown in Fig. 4 revealed no significant differences at any time points between any of the groups. The exception to this was a significantly higher surface tension at 1 and 5 s only for the sample from the untreated low Vt group supplemented with cholesterol compared with the samples from untreated low Vt group (results not shown).
The MST values during dynamic compression-expansion cycling of the bubble, for the samples in experiment 2, are shown in Fig. 5 . Comparison of the untreated low Vt and high Vt groups revealed higher MST over all cycles in high Vt samples (Fig. 5A) . In M␤CD-treated samples (Fig. 5B) , comparison of high Vt M␤CD-treated to low Vt M␤CD-treated revealed a higher MST in high Vt samples over cycles 2, 5, 10 , and 20, but no difference at cycle 1. Comparison between untreated low Vt and the M␤CD-treated low Vt samples revealed no significant differences over cycles 1, 2, 5, or 10; however, cycle 20 was significantly lower in M␤CD-treated surfactant samples (Fig. 5, A and B) . The effect of M␤CD in the high Vt groups was more marked than that in the low Vt (Fig. 5, A and  B) . As shown in Fig. 4C , addition of cholesterol to M␤CD-treated low Vt samples compared with M␤CD-treated high Vt samples revealed a higher MST over all cycles analyzed in samples from animals receiving high Vt. Comparison of these samples to their respective untreated samples (Fig. 5 , A vs. C) revealed similar MST over all cycles analyzed. Finally, statistical analysis of low Vt samples with added cholesterol revealed higher MST over cycles 1, 2, 5, and 10 compared with untreated low Vt.
DISCUSSION
The purpose of this study was to investigate the contribution of cholesterol to the biophysical dysfunction of surfactant observed in VILI. The rationale was that 1) MV is known to contribute to the progression of lung injury in patients with ALI/ARDS (5), 2) the neutral lipid component of surfactant, which includes cholesterol, was increased in patients with ALI/ARDS (22) and in VILI (23) , and 3) adding cholesterol to exogenous surfactant preparations inhibited surfactant function (12, 13, 18, 20, 33) . Our study expanded on these studies by demonstrating, for the first time, that cholesterol-mediated inhibition of surfactant function occurred with samples from an in vivo model. We conclude that increased levels of cholesterol represent a major contributor to the inhibition of surfactant function in VILI. It is speculated that this inhibition may play a role in surfactant dysfunction during MV in the setting of ALI and as such contribute to the progression of lung injury due to MV.
The experimental model utilized to obtain the various LA fractions studied was an established model of MV known to induce VILI in rats (23) . Lung dysfunction was verified by demonstrating a severe reduction in Pa O 2 /FI O 2 and compliance over 2 h and an increase in PIP values. To specifically study the contribution of cholesterol, the large surfactant aggregates obtained from these animals were extracted with organic solvent to remove nonsurfactant proteins as well as SP-A and SP-D. The extracted samples, containing the hydrophobic components of surfactant, were subsequently analyzed for their ability to reduce surface tension using two complementary approaches. In experiment 1, M␤CD was added to the buffer within the chamber of the CBS where it would complex with, and remove, cholesterol from the surfactant film during the 1-h incubation period (28, 42) . This method is suitable for the analysis of the role of cholesterol in surfactant using only a very small amount of material and can therefore be utilized in future studies with samples from clinical studies, in which the surfactant yield is often limited. In experiment 2, cholesterol was removed from the samples before surface activity measurements. This method allowed us to verify the effect of cholesterol via the addition of exogenous cholesterol to these samples before the introduction of this material into the CBS. It should be noted that the efficacy of cholesterol removal by M␤CD was based on preliminary studies using radioactive cholesterol, and cholesterol levels were not measured in the actual samples used. Using the CBS, we examined surface tension during adsorption, expansion, and compression in LA samples obtained from the various groups.
The main result from the two experiments was that incubation of surfactant samples obtained from animals with VILI (i.e., the high Vt group) with M␤CD resulted in an improvement in the ability of the surfactant to reduce surface tension to low values. Cyclodextrins, such as M␤CD, are large cyclic oligosaccharides that possess a polar exterior and a hydrophobic internal cavity; they bind cholesterol, other sterols, and a number of aromatic compounds, including certain drugs and chlorophyll (42) . In the context of surfactant composition, M␤CD would remove mainly cholesterol from the surfactant samples. Nevertheless, because of these reports supporting the potential removal of compounds other than cholesterol, it was considered important to demonstrate that the increase in cho- lesterol observed with high Vt LA was responsible for deterioration of biophysical activity. In brief, the experiments showed that samples with restored cholesterol levels had similar activities as the original samples. In addition, elevating cholesterol levels in the samples from the low Vt group (ϳ8% cholesterol) to levels similar to those observed in the high Vt group (ϳ13% cholesterol) (23) resulted in an impaired activity similar to the nonsupplemented high Vt samples. Together, these results provide strong evidence that elevated cholesterol is a major contributor to the dysfunction of surfactant in VILI. It should be noted, however, that this evidence for the inhibitory activity of cholesterol does not preclude the possibility of a role for other inhibitory components that may have been removed during the purification and extraction procedures of the surfactant in this study.
Whereas the overall interpretation of the two experiments was similar, there were also two specific differences between the results from the different approaches that warrant discussion. First, the observed effects of M␤CD on the adsorption step of the activity measurement differed between experiment 1 and experiment 2. In experiment 1, M␤CD did not have an effect on the adsorption values, whereas in experiment 2, M␤CD treatment affected adsorption of samples obtained from both the low Vt and high Vt groups. This difference likely relates to the fact that adsorption in experiment 1 occurred by injection of the cholesterol-containing material into the CBS, with subsequent removal of cholesterol from the adsorbed film by incubation with M␤CD. In contrast, experiment 2 measured the adsorption of samples that had cholesterol removed before injection into the CBS. Thus, interpreting the data regarding the role of cholesterol on adsorption specifically can only be based on experiment 2. The results showed a reduced adsorption in samples from the high Vt group compared with the low Vt group that improved upon treatment with M␤CD, which is consistent with an inhibitory role of elevated cholesterol. However, treatment of the low Vt samples with M␤CD resulted in a reduced adsorption compared with the nontreated low Vt sample. Thus, it appears that elevated cholesterol can inhibit surfactant adsorption, but also that physiological levels of cholesterol are required for normal rapid adsorption. These observations are consistent with previous suggestions that physiological levels of cholesterol enhance the ability of pulmonary surfactant to adsorb to equilibrium surface tension at the air-liquid interface (3, 41) .
A second difference between the two approaches relates to the MST values obtained during compression. Whereas the MST of untreated samples from low Vt and high Vt groups were similar between the two experiments, the MST obtained over consecutive cycles was different between the two experiments after M␤CD exposure. Specifically, in experiment 1, the MST remained low, whereas in experiment 2, the MST increased over the different cycles measured. It is speculated that this difference in results could be related to difference in the manner or the extent of cholesterol removal between the two approaches. In experiment 1, cholesterol was directly removed from the adsorbed film, which was subsequently analyzed for the MST. The amount of cholesterol removed by this method could not be assessed. In contrast, in experiment 2, ϳ80 -85% of the cholesterol was removed by the M␤CD treatment, and the material was depleted before the adsorption step. It is also possible that the differences in adsorption due to cholesterol, as described above, may have affected the subsequent MST measurements. This will require further study.
Regardless of the specific differences between our two approaches, the overall interpretation of both experiments clearly implicates elevated cholesterol as an important inhibitor of surfactant function. The potential molecular mechanism by which increased levels of cholesterol affect the surface tension reducing ability of surfactant during compression stems mostly from reconstitution studies with high amounts of cholesterol added to exogenous surfactant preparations (8, 12, 13, 18, 19) . Consistent with our results, addition of 20% cholesterol (by weight) to an exogenous surfactant preparation resulted in an inability to achieve low MST values during the compression phase of dynamic cycling. In addition, atomic force microscopy of the surface films demonstrated that high cholesterol alters the lateral organization of surfactant (18, 19) . Specifically, these studies, as well as other experiments with pure lipid films, demonstrated that supraphysiological levels of cholesterol increase surfactant rigidity due to the interaction of cholesterol with more fluid-like lipids (such as the unsaturated lipids of surfactant) (29, 43) . This effect is not observed with normal physiological levels of cholesterol, where an interaction occurs between cholesterol and the rigid lipids, which enhances the fluidity (20, 29, 43) . Furthermore, it has also been observed that surface films of surfactant with high cholesterol had a tendency to collapse at higher surface tension (13, 20, 30) . For example, using atomic force microscopy, it was determined that the lack of film stability in the presence of elevated levels of cholesterol was correlated to an inhibition of a monolayer-to-bilayer conversion (20) . Functional surfactant films, containing physiological amounts of cholesterol, underwent a monolayer-to-bilayer conversion upon film compression and resulted in a film with lipid bilayer stacks scattered over a lipid monolayer, whereas the films formed from surfactant with elevated cholesterol formed only a few stacks (20) . Overall, these biophysical studies suggest that the increased cholesterol in our samples obtained from animals with VILI decreased the surfactant fluidity and that this may lead to the impaired ability to reach low surface tension during compression due to collapse of the surface film. However, more detailed investigation of the mechanism by which increased levels of cholesterol inhibit surfactant function is warranted.
The current finding that an increased level of cholesterol in surfactant contributes significantly to surfactant impairment may have important clinical significance. Although most of the research on surfactant dysfunction in VILI and ALI/ARDS has focused on serum protein inhibition (17, 27, 43) , it has recently been reported that surfactant from patients with ALI/ARDS had increased levels of neutral lipid, and this was thought to contribute to surfactant dysfunction (22) . Thus, inhibition by elevated cholesterol levels represents an additional mechanism that could be targeted in studies to limit surfactant dysfunction. It should be noted that the mechanism by which serum proteins inhibit pulmonary surfactant differs from that observed with cholesterol. With proteins, inhibition can normally be relieved through repeated compression-expansion cycling (43) . With cholesterol-mediated inhibition, compression-expansion cycling does not relieve inhibition and may even result in higher MST, as observed in our experiments. In this context, it would also be informative to elucidate the source of the elevated cholesterol in surfactant obtained in our model of VILI and in patients with ALI/ARDS. In the healthy lung, it is widely accepted that most (99%) surfactant-associated cholesterol is derived from serum lipoproteins (15, 16) . Cholesterol from serum lipoproteins is taken up by the type II cell and incorporated into the surfactant before secretion (15) . Furthermore, it has recently been demonstrated that mice fed a high cholesterol diet exhibit an increased level of serum cholesterol and that the surfactant obtained from these mice had increased cholesterol values with impaired biophysical function (24) . However, Davidson et al. (7) demonstrated that lowering levels of serum cholesterol by inhibiting the release of hepatic lipoproteins did not affect surfactant cholesterol levels, due to the ability of type II cells to synthesize cholesterol. These findings provide evidence that, at least in the uninjured lung, surfactant cholesterol arises from the serum and/or de novo synthesis. In contrast, the source of cholesterol in VILI has yet to be determined. Further investigation into the source of the increased levels of cholesterol is warranted if treatment strategies are to be aimed at mitigating the increase in surfactant cholesterol observed in VILI.
